SCHEMBL22178483

SCHEMBL22178483

c1ccc(-c2ccc(-c3cc(-c4cccc5oc6cccc(-c7nc8ccccc8s7)c6c45)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.42
▸ RAB9A P51151 7/20 0.42
▸ MEN1 O00255 6/20 0.42
▸ KMT2A Q03164 6/20 0.42
▸ KDM4E B2RXH2 6/20 0.42
▸ ALDH1A1 P00352 6/20 0.42
▸ NPC1 O15118 5/20 0.42
▸ NFKB1 P19838 4/20 0.42
▸ NFKB2 Q00653 4/20 0.42
▸ RELA Q04206 4/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ LMNA P02545 3/20 0.42
▸ TP53 P04637 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ APP P05067 2/20 0.42
▸ GAA P10253 3/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ GLA P06280 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22177546 0.98 RAB9A (0.44) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22177539 0.97 APP (0.44) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22178484 0.94 RAB9A (0.41) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22177609 0.93 RAB9A (0.44) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22177548 0.91 APP (0.39) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22178412 0.91 RAB9A (0.46) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22177490 0.91 RAB9A (0.46) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22177552 0.90 RAB9A (0.45) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22177219 0.90 RAB9A (0.45) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL22178513 0.89 RAB9A (0.47) MAPTRAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same LG CHEM, LTD. (KR) 2022-12-06 — — US disclosed
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, CYP1A1 MAPT 1997/4885RAB9A 2411/4885MEN1 344/4885
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same CRY1, CYP1A1, CRY2 MAPT 1660/4885RAB9A 2545/4885MEN1 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback